Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Petersen J, Ludwig MQ, Juozaityte V, Ranea-Robles P, Svendsen C, Hwang E et al (2024) GLP-1-directed NMDA receptor antagonism for obesity treatment
These results support the rationale of developing retatrutide as an alternative to semaglutide and/or tirzepatide 5
, , ,
Medical Director, Heart and Vascular Center of Excellence Chief, Division of Cardiovascular Medicine University of Massachusetts Medical School and Memorial Medical Center Mary C
Forcina, L., Miano, C., Scicchitano, B
US$ 27.95
US$ 27.69
US$ 21.62
US$ 23.48
US$ 25.54
